1. Home
  2. MGIC vs ICUCW Comparison

MGIC vs ICUCW Comparison

Compare MGIC & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGIC
  • ICUCW
  • Stock Information
  • Founded
  • MGIC 1983
  • ICUCW N/A
  • Country
  • MGIC Israel
  • ICUCW United States
  • Employees
  • MGIC N/A
  • ICUCW 12
  • Industry
  • MGIC Computer Software: Prepackaged Software
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGIC Technology
  • ICUCW Health Care
  • Exchange
  • MGIC Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • MGIC N/A
  • ICUCW N/A
  • IPO Year
  • MGIC 1991
  • ICUCW 2021
  • Fundamental
  • Price
  • MGIC $11.13
  • ICUCW $0.03
  • Analyst Decision
  • MGIC Buy
  • ICUCW
  • Analyst Count
  • MGIC 1
  • ICUCW 0
  • Target Price
  • MGIC $14.00
  • ICUCW N/A
  • AVG Volume (30 Days)
  • MGIC 32.1K
  • ICUCW N/A
  • Earning Date
  • MGIC 11-19-2024
  • ICUCW N/A
  • Dividend Yield
  • MGIC 1.82%
  • ICUCW N/A
  • EPS Growth
  • MGIC N/A
  • ICUCW N/A
  • EPS
  • MGIC 0.72
  • ICUCW N/A
  • Revenue
  • MGIC $523,332,000.00
  • ICUCW N/A
  • Revenue This Year
  • MGIC $3.87
  • ICUCW N/A
  • Revenue Next Year
  • MGIC $3.39
  • ICUCW N/A
  • P/E Ratio
  • MGIC $15.84
  • ICUCW N/A
  • Revenue Growth
  • MGIC N/A
  • ICUCW N/A
  • 52 Week Low
  • MGIC $8.40
  • ICUCW N/A
  • 52 Week High
  • MGIC $12.99
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MGIC 49.50
  • ICUCW N/A
  • Support Level
  • MGIC $10.42
  • ICUCW N/A
  • Resistance Level
  • MGIC $11.41
  • ICUCW N/A
  • Average True Range (ATR)
  • MGIC 0.27
  • ICUCW 0.00
  • MACD
  • MGIC -0.00
  • ICUCW 0.00
  • Stochastic Oscillator
  • MGIC 54.20
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: